• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For May 16, 2022

    5/16/22 5:18:44 AM ET
    $ACRX
    $ADMP
    $ALBO
    $AMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACRX alert in real time by email

     

    Companies Reporting Before The Bell

    • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

    • Synthetic Biologics (AMEX:SYN) is likely to report earnings for its first quarter.

    • Passage Bio (NASDAQ:PASG) is estimated to report earnings for its first quarter.

    • Taysha Gene Therapies (NASDAQ:TSHA) is expected to report earnings for its first quarter.

    • HOOKIPA Pharma (NASDAQ:HOOK) is likely to report quarterly loss at $0.24 per share on revenue of $14.53 million.

    • Sunworks (NASDAQ:SUNW) is likely to report quarterly loss at $0.26 per share on revenue of $28.70 million.

    • Data Storage (NASDAQ:DTST) is estimated to report quarterly earnings at $0.01 per share on revenue of $6.00 million.

    • 1847 Goedeker (AMEX:GOED) is projected to report quarterly earnings at $0.04 per share on revenue of $152.35 million.

    • BIO-key Intl (NASDAQ:BKYI) is estimated to report quarterly loss at $0.22 per share on revenue of $1.25 million.

    • Orbital Energy Group (NASDAQ:OEG) is expected to report quarterly loss at $0.05 per share on revenue of $70.49 million.

    • Pyxis Tankers (NASDAQ:PXS) is estimated to report quarterly loss at $0.02 per share on revenue of $6.60 million.

    • SPDR Select Sector Fund - Consumer Discretionary (NYSE:XLY) is expected to report quarterly loss at $0.02 per share on revenue of $29.62 million.

    • Grupo Televisa (NYSE:TV) is estimated to report quarterly earnings at $0.17 per share on revenue of $115.80 million.

    • Mind Medicine (NASDAQ:MNMD) is expected to report earnings for its first quarter.

    • ATAI Life Sciences (NASDAQ:ATAI) is expected to report earnings for its first quarter.

    • Ryanair Holdings (NASDAQ:RYAAY) is expected to report quarterly loss at $1.02 per share on revenue of $1.36 billion.

    • Greenland Technologies (NASDAQ:GTEC) is projected to report quarterly earnings at $0.09 per share on revenue of $24.36 million.

    • Weber (NYSE:WEBR) is projected to report quarterly earnings at $0.18 per share on revenue of $659.06 million.

    • Protalix BioTherapeutics (AMEX:PLX) is projected to report earnings for its first quarter.

    • SPAR Group (NASDAQ:SGRP) is expected to report earnings for its first quarter.

    • Quanergy Systems (NYSE:QNGY) is expected to report earnings for its first quarter.

    • Enjoy Technology (NASDAQ:ENJY) is projected to report quarterly loss at $0.40 per share on revenue of $24.15 million.

    • Chimerix (NASDAQ:CMRX) is projected to report earnings for its first quarter.

    • Brainstorm Cell (NASDAQ:BCLI) is projected to report earnings for its first quarter.

    • Lottery.com (NASDAQ:LTRY) is projected to report quarterly loss at $0.19 per share on revenue of $22.70 million.

    • Clear Secure (NYSE:YOU) is projected to report quarterly loss at $0.12 per share on revenue of $88.31 million.

    • Benson Hill (NYSE:BHIL) is expected to report quarterly loss at $0.20 per share on revenue of $74.52 million.

    • Gracell Biotechnologies (NASDAQ:GRCL) is likely to report earnings for its first quarter.

    • Compugen (NASDAQ:CGEN) is likely to report earnings for its first quarter.

    • Monday.Com (NASDAQ:MNDY) is estimated to report quarterly loss at $1.02 per share on revenue of $101.22 million.

    • Warby Parker (NYSE:WRBY) is likely to report quarterly earnings at $0.01 per share on revenue of $154.05 million.

    • Kala Pharmaceuticals (NASDAQ:KALA) is likely to report quarterly loss at $0.36 per share on revenue of $3.07 million.

    • Tower Semiconductor (NASDAQ:TSEM) is estimated to report earnings for its first quarter.

    • Wix.com (NASDAQ:WIX) is projected to report quarterly loss at $0.64 per share on revenue of $340.55 million.

    • Celsion (NASDAQ:CLSN) is likely to report quarterly loss at $0.99 per share on revenue of $100.00 thousand.

    • Impel Pharmaceuticals (NASDAQ:IMPL) is projected to report quarterly loss at $1.05 per share on revenue of $1.80 million.

    • Recruiter.Com Group (NASDAQ:RCRT) is estimated to report quarterly loss at $0.29 per share on revenue of $7.14 million.

    • S&W Seed (NASDAQ:SANW) is likely to report quarterly loss at $0.09 per share on revenue of $23.75 million.

    • Novan (NASDAQ:NOVN) is likely to report quarterly loss at $0.60 per share on revenue of $1.35 million.

    • U.S. Well Services (NASDAQ:USWS) is projected to report quarterly loss at $0.28 per share on revenue of $39.40 million.

    • Altus Power (NYSE:AMPS) is projected to report quarterly loss at $0.02 per share on revenue of $19.60 million.

    • Alaunos Therapeutics (NASDAQ:TCRT) is expected to report earnings for its first quarter.

    • Fathom Digital Mfg (NYSE:FATH) is projected to report earnings for its first quarter.

    • Luna Innovations (NASDAQ:LUNA) is expected to report quarterly earnings at $0.01 per share on revenue of $21.23 million.

    • Syros Pharmaceuticals (NASDAQ:SYRS) is expected to report quarterly loss at $0.47 per share on revenue of $4.92 million.

    • PolarityTE (NASDAQ:PTE) is likely to report quarterly loss at $0.08 per share on revenue of $730.00 thousand.

    • Stratus Properties (NASDAQ:STRS) is likely to report earnings for its first quarter.

    • NRX Pharmaceuticals (NASDAQ:NRXP) is expected to report earnings for its first quarter.

    • Sohu.com (NASDAQ:SOHU) is likely to report earnings for its first quarter.

    • Bitfarms (NASDAQ:BITF) is projected to report earnings for its first quarter.

    • Modiv (NYSE:MDV) is likely to report earnings for its first quarter.

    Companies Reporting After The Bell

    • Sundial Growers (NASDAQ:SNDL) is estimated to report earnings for its first quarter.

    • Verb Tech (NASDAQ:VERB) is estimated to report quarterly loss at $0.06 per share on revenue of $3.06 million.

    • Inpixon (NASDAQ:INPX) is likely to report earnings for its first quarter.

    • GSE Systems (NASDAQ:GVP) is expected to report earnings for its first quarter.

    • Ra Medical Systems (AMEX:RMED) is likely to report earnings for its first quarter.

    • CynergisTek (AMEX:CTEK) is estimated to report quarterly loss at $0.11 per share on revenue of $4.33 million.

    • BurgerFi International (NASDAQ:BFI) is likely to report earnings for its first quarter.

    • Helbiz (NASDAQ:HLBZ) is expected to report earnings for its first quarter.

    • XpresSpa Group (NASDAQ:XSPA) is estimated to report quarterly loss at $0.06 per share on revenue of $19.42 million.

    • Arcimoto (NASDAQ:FUV) is expected to report quarterly loss at $0.30 per share on revenue of $1.33 million.

    • Quest Resource Holding (NASDAQ:QRHC) is projected to report quarterly earnings at $0.03 per share on revenue of $60.50 million.

    • TherapeuticsMD (NASDAQ:TXMD) is projected to report quarterly loss at $4.00 per share on revenue of $17.95 million.

    • Adamis Pharmaceuticals (NASDAQ:ADMP) is estimated to report quarterly loss at $0.03 per share on revenue of $3.76 million.

    • Ginkgo Bioworks Holdings (NYSE:DNA) is expected to report quarterly loss at $0.03 per share on revenue of $105.68 million.

    • Natural Gas Services Gr (NYSE:NGS) is projected to report quarterly loss at $0.16 per share on revenue of $18.10 million.

    • Inhibikase Therapeutics (NASDAQ:IKT) is expected to report quarterly loss at $0.17 per share on revenue of $300.00 thousand.

    • Yalla Group (NYSE:YALA) is projected to report quarterly earnings at $0.14 per share on revenue of $70.20 million.

    • Global E Online (NASDAQ:GLBE) is estimated to report earnings for its first quarter.

    • OMNIQ (NASDAQ:OMQS) is expected to report quarterly loss at $0.25 per share on revenue of $24.93 million.

    • Vislink Technologies (NASDAQ:VISL) is estimated to report quarterly loss at $0.04 per share on revenue of $7.57 million.

    • Nu Holdings (NYSE:NU) is likely to report earnings for its first quarter.

    • PyroGenesis Canada (NASDAQ:PYR) is likely to report earnings for its first quarter.

    • Flotek Industries (NYSE:FTK) is likely to report quarterly loss at $0.06 per share on revenue of $11.80 million.

    • AutoWeb (NASDAQ:AUTO) is expected to report quarterly loss at $0.17 per share on revenue of $18.73 million.

    • Celcuity (NASDAQ:CELC) is estimated to report earnings for its first quarter.

    • CVD Equipment (NASDAQ:CVV) is estimated to report earnings for its first quarter.

    • Ark Restaurants (NASDAQ:ARKR) is expected to report earnings for its second quarter.

    • Albireo Pharma (NASDAQ:ALBO) is estimated to report quarterly loss at $1.85 per share on revenue of $7.96 million.

    • Dada Nexus (NASDAQ:DADA) is expected to report quarterly loss at $0.24 per share on revenue of $300.34 million.

    • Clarus Therapeutics Hldgs (NASDAQ:CRXT) is expected to report quarterly loss at $0.40 per share on revenue of $5.50 million.

    • Stewart Information Servs (NYSE:STC) is projected to report quarterly loss at $0.05 per share on revenue of $61.62 million.

    • HyreCar (NASDAQ:HYRE) is projected to report quarterly loss at $0.24 per share on revenue of $9.54 million.

    • Mawson Infra Gr (NASDAQ:MIGI) is expected to report quarterly loss at $0.08 per share on revenue of $20.60 million.

    • Rockwell Medical (NASDAQ:RMTI) is expected to report quarterly loss at $0.09 per share on revenue of $17.65 million.

    • iSun (NASDAQ:ISUN) is expected to report quarterly loss at $0.02 per share on revenue of $28.27 million.

    • Bird Glb (NYSE:BRDS) is estimated to report quarterly loss at $0.12 per share on revenue of $35.73 million.

    • Vitru (NASDAQ:VTRU) is likely to report earnings for its first quarter.

    • Eastside Distilling (NASDAQ:EAST) is expected to report quarterly loss at $0.18 per share on revenue of $2.75 million.

    • Rocket Lab USA (NASDAQ:RKLB) is estimated to report earnings for its first quarter.

    • Direxion Daily CSI China Internet Index Bull 2X Shares (NYSE:CWEB) is expected to report quarterly loss at $0.07 per share on revenue of $30.57 million.

    • Energy Vault Holdings (NYSE:NRGV) is likely to report earnings for its first quarter.

    • Stronghold Digital Mining (NASDAQ:SDIG) is estimated to report quarterly loss at $0.02 per share on revenue of $26.94 million.

    • AST SpaceMobile (NASDAQ:ASTS) is expected to report earnings for its first quarter.

    • Vintage Wine Estates (NASDAQ:VWE) is expected to report earnings for its third quarter.

    • Stratasys (NASDAQ:SSYS) is expected to report quarterly loss at $0.04 per share on revenue of $157.56 million.

    • Take-Two Interactive (NASDAQ:TTWO) is expected to report quarterly earnings at $1.04 per share on revenue of $882.10 million.

    • CYREN (NASDAQ:CYRN) is estimated to report earnings for its first quarter.

    • Shoals Technologies Gr (NASDAQ:SHLS) is estimated to report quarterly earnings at $0.07 per share on revenue of $70.38 million.

    • Shapeways Hldgs (NYSE:SHPW) is expected to report quarterly loss at $0.14 per share on revenue of $7.34 million.

    • Sunlight Finl Hldgs (NYSE:SUNL) is expected to report quarterly earnings at $0.03 per share on revenue of $29.45 million.

    • Consensus Cloud Solutions (NASDAQ:CCSI) is likely to report quarterly earnings at $1.26 per share on revenue of $90.93 million.

    • Tencent Music Enter Gr (NYSE:TME) is likely to report quarterly earnings at $0.07 per share on revenue of $1.23 billion.

    • Miromatrix Medical (NASDAQ:MIRO) is expected to report earnings for its first quarter.

    • IonQ (NYSE:IONQ) is projected to report quarterly loss at $0.08 per share on revenue of $1.93 million.

    • BuzzFeed (NASDAQ:BZFD) is estimated to report quarterly loss at $0.21 per share on revenue of $94.46 million.

    • Creative Realities (NASDAQ:CREX) is estimated to report earnings for its first quarter.

    • Kore Group Holdings (NYSE:KORE) is likely to report quarterly loss at $0.09 per share on revenue of $62.31 million.

    • Flexible Solutions Intl (AMEX:FSI) is likely to report quarterly earnings at $0.04 per share on revenue of $9.39 million.

    • WidePoint (AMEX:WYY) is estimated to report earnings for its first quarter.

    • CohBar (NASDAQ:CWBR) is expected to report earnings for its first quarter.

    • GAN (NASDAQ:GAN) is estimated to report quarterly loss at $0.10 per share on revenue of $34.41 million.

    • Remark Hldgs (NASDAQ:MARK) is estimated to report earnings for its first quarter.

    • IZEA Worldwide (NASDAQ:IZEA) is projected to report quarterly loss at $0.02 per share on revenue of $9.00 million.

    • Super League Gaming (NASDAQ:SLGG) is projected to report quarterly loss at $0.21 per share on revenue of $3.12 million.

    • Pear Therapeutics (NASDAQ:PEAR) is expected to report quarterly loss at $0.24 per share on revenue of $2.40 million.

    • Vivos Therapeutics (NASDAQ:VVOS) is projected to report quarterly loss at $0.26 per share on revenue of $4.44 million.

    • Glimpse Group (NASDAQ:VRAR) is likely to report earnings for its third quarter.

    • Reed's (NASDAQ:REED) is likely to report quarterly loss at $0.04 per share on revenue of $13.10 million.

    • Assure Hldgs (NASDAQ:IONM) is estimated to report quarterly loss at $0.08 per share on revenue of $6.75 million.

    • Motorsport Games (NASDAQ:MSGM) is projected to report quarterly loss at $0.50 per share on revenue of $1.78 million.

    • VOXX International (NASDAQ:VOXX) is estimated to report earnings for its fourth quarter.

    • GreenBox POS (NASDAQ:GBOX) is estimated to report quarterly loss at $0.15 per share on revenue of $10.14 million.

    • Park City Gr (NASDAQ:PCYG) is likely to report quarterly earnings at $0.05 per share on revenue of $4.52 million.

    • Nerdy (NYSE:NRDY) is projected to report quarterly loss at $0.11 per share on revenue of $46.74 million.

    • Ideal Power (NASDAQ:IPWR) is projected to report quarterly loss at $0.25 per share on revenue of $200.00 thousand.

    • KULR Tech Gr (AMEX:KULR) is estimated to report quarterly loss at $0.03 per share on revenue of $710.00 thousand.

    • Accelerate Diagnostics (NASDAQ:AXDX) is expected to report quarterly loss at $0.30 per share on revenue of $2.95 million.

    • Pioneer Power Solutions (NASDAQ:PPSI) is projected to report quarterly loss at $0.07 per share on revenue of $4.45 million.

    • Kidpik (NASDAQ:PIK) is projected to report quarterly loss at $0.31 per share on revenue of $4.70 million.

    • Blackboxstocks (NASDAQ:BLBX) is expected to report quarterly loss at $0.05 per share on revenue of $1.91 million.

    • Spero Therapeutics (NASDAQ:SPRO) is estimated to report quarterly loss at $0.87 per share on revenue of $2.57 million.

    • Rekor Systems (NASDAQ:REKR) is projected to report quarterly loss at $0.22 per share on revenue of $3.30 million.

    • Duos Technologies Group (NASDAQ:DUOT) is projected to report quarterly loss at $0.53 per share on revenue of $1.00 million.

    • HighPeak Energy (NASDAQ:HPK) is expected to report quarterly earnings at $0.49 per share on revenue of $112.70 million.

    • iPower (NASDAQ:IPW) is estimated to report quarterly earnings at $0.03 per share on revenue of $17.60 million.

    • American Res (NASDAQ:AREC) is expected to report earnings for its first quarter.

    • Kubient (NASDAQ:KBNT) is projected to report quarterly loss at $0.23 per share on revenue of $800.00 thousand.

    • Enthusiast Gaming (NASDAQ:EGLX) is projected to report earnings for its first quarter.

    • Vicinity Motor (NASDAQ:VEV) is expected to report earnings for its first quarter.

    • Tivic Health Systems (NASDAQ:TIVC) is likely to report earnings for its first quarter.

    • Sanara MedTech (NASDAQ:SMTI) is likely to report earnings for its first quarter.

    • Sphere 3D (NASDAQ:ANY) is likely to report earnings for its first quarter.

    • Rigetti Computing (NASDAQ:RGTI) is likely to report earnings for its first quarter.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACRX
    $ADMP
    $ALBO
    $AMPS

    CompanyDatePrice TargetRatingAnalyst
    Stewart Information Services Corporation
    $STC
    2/27/2026$82.00Equal-Weight → Overweight
    Stephens
    Clear Secure Inc.
    $YOU
    2/26/2026$45.00 → $55.00Outperform
    Telsey Advisory Group
    Shoals Technologies Group Inc.
    $SHLS
    2/25/2026$9.00Underperform → Neutral
    BNP Paribas Exane
    monday.com Ltd.
    $MNDY
    2/23/2026$80.00Buy → Hold
    Jefferies
    Ryanair Holdings plc
    $RYAAY
    2/18/2026Buy → Hold
    Erste Group
    Rigetti Computing Inc.
    $RGTI
    2/12/2026Buy → Hold
    TD Cowen
    monday.com Ltd.
    $MNDY
    2/10/2026$80.00Buy → Hold
    Loop Capital
    monday.com Ltd.
    $MNDY
    2/10/2026$90.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ACRX
    $ADMP
    $ALBO
    $AMPS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stewart Info upgraded by Stephens with a new price target

    Stephens upgraded Stewart Info from Equal-Weight to Overweight and set a new price target of $82.00

    2/27/26 8:22:48 AM ET
    $STC
    Specialty Insurers
    Finance

    Telsey Advisory Group reiterated coverage on Clear Secure with a new price target

    Telsey Advisory Group reiterated coverage of Clear Secure with a rating of Outperform and set a new price target of $55.00 from $45.00 previously

    2/26/26 6:51:04 AM ET
    $YOU
    Computer Software: Prepackaged Software
    Technology

    Shoals Technologies upgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane upgraded Shoals Technologies from Underperform to Neutral and set a new price target of $9.00

    2/25/26 7:38:45 AM ET
    $SHLS
    Semiconductors
    Technology

    $ACRX
    $ADMP
    $ALBO
    $AMPS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mission Success: Rocket Lab Launches 2nd Hypersonic Test Mission in Three Months for Defense Innovation Unit

    LONG BEACH, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today successfully launched its latest hypersonic test mission on its HASTE rocket for the Department of War's Defense Innovation Unit (DIU) – supporting a critical national priority to advance hypersonic technology for the United States and its allies. "That's Not A Knife" lifted off on February 27 at 7:00 p.m. Eastern (February 28, 00:00 UTC) from Rocket Lab Launch Complex 2 within the Virginia Spaceport Authority's Mid-Atlantic Regional Spaceport on Wallops Island, Virginia – the second successful launch of a h

    2/27/26 7:40:52 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments

    Issued on behalf of Helus PharmaVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity-Insider.com News Commentary -- Psychedelic compounds are edging closer to regulatory approval as pivotal trials in treatment-resistant depression and anxiety advance through late-stage development[1]. The sector is shedding its countercultural reputation as biotech firms reposition serotonergic and psychedelic-derived therapies as mainstream pharmaceutical candidates[2]. Five companies are building the clinical programs to get there: Helus Pharma (NASDAQ:HELP), AtaiBeckley (NASDAQ:ATAI), Definium Therapeutics (NASDAQ:DFTX), GH Research (NASDAQ:GHRS), and LB Pharmaceuticals (NASDAQ:LBRX).

    2/27/26 11:44:00 AM ET
    $ATAI
    $DFTX
    $GHRS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medicinal Chemicals and Botanical Products

    Ideal Power to Host Fourth Quarter and Full Year 2025 Results Conference Call on March 10, 2026 at 10:00 AM Eastern Time

    AUSTIN, Texas, Feb. 27, 2026 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and provider of its innovative and widely patented B-TRAN® bidirectional semiconductor power switch, today announced management will hold a conference call on Tuesday, March 10, 2026 at 10:00 AM Eastern Time to discuss its results for the fourth quarter and full year ended December 31, 2025. A press release detailing these results will be issued prior to the call.Ideal Power management will host the conference call, followed by a question-and-answer period. Analysts and investors may pose questions for management during the live conference call on March 1

    2/27/26 9:20:00 AM ET
    $IPWR
    Semiconductors
    Technology

    $ACRX
    $ADMP
    $ALBO
    $AMPS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Piconi Robert bought $24,412 worth of shares (7,500 units at $3.25), increasing direct ownership by 0.04% to 20,090,637 units (SEC Form 4)

    4 - Energy Vault Holdings, Inc. (0001828536) (Issuer)

    2/26/26 1:47:43 PM ET
    $NRGV
    Industrial Machinery/Components
    Miscellaneous

    President and CEO Somo David M bought $250,000 worth of shares (90,909 units at $2.75), increasing direct ownership by 37% to 338,347 units (SEC Form 4)

    4 - Ideal Power Inc. (0001507957) (Issuer)

    2/26/26 8:49:32 AM ET
    $IPWR
    Semiconductors
    Technology

    Large owner Endeavor Blockchain, Llc bought $192,502 worth of shares (42,100 units at $4.57), decreasing direct ownership by 100% to 4,397 units (SEC Form 4)

    4 - Mawson Infrastructure Group Inc. (0001218683) (Issuer)

    1/30/26 7:58:02 PM ET
    $MIGI
    Finance: Consumer Services
    Finance

    $ACRX
    $ADMP
    $ALBO
    $AMPS
    SEC Filings

    View All

    IonQ Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - IonQ, Inc. (0001824920) (Filer)

    2/27/26 5:23:08 PM ET
    $IONQ
    EDP Services
    Technology

    SEC Form 10-K filed by Stewart Information Services Corporation

    10-K - STEWART INFORMATION SERVICES CORP (0000094344) (Filer)

    2/27/26 5:22:19 PM ET
    $STC
    Specialty Insurers
    Finance

    SEC Form 424B7 filed by IonQ Inc.

    424B7 - IonQ, Inc. (0001824920) (Filer)

    2/27/26 5:15:43 PM ET
    $IONQ
    EDP Services
    Technology

    $ACRX
    $ADMP
    $ALBO
    $AMPS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-6) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 12/28/2021. Application Category: NDA, Application Number: 210132, Application Classification: Efficacy

    12/29/21 7:23:57 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IMVEXXY issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug IMVEXXY (SUPPL-2) with active ingredient ESTRADIOL has changed to 'Approval' on 11/16/2021. Application Category: NDA, Application Number: 208564, Application Classification: Labeling

    11/17/21 4:38:32 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZIMHI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug ZIMHI (ORIG-1) with active ingredient NALOXONE HYDROCHLORIDE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 212854, Application Classification: Type 5 - New Formulation or New Manufacturer

    10/18/21 11:55:40 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRX
    $ADMP
    $ALBO
    $AMPS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wiener Adam sold $1,525,280 worth of shares (33,000 units at $46.22), decreasing direct ownership by 20% to 132,634 units (SEC Form 4)

    4 - Clear Secure, Inc. (0001856314) (Issuer)

    2/27/26 7:47:03 PM ET
    $YOU
    Computer Software: Prepackaged Software
    Technology

    GC & Chief Privacy Officer Haaland Lynn sold $698,986 worth of shares (15,533 units at $45.00), closing all direct ownership in the company (SEC Form 4)

    4 - Clear Secure, Inc. (0001856314) (Issuer)

    2/27/26 7:45:33 PM ET
    $YOU
    Computer Software: Prepackaged Software
    Technology

    Large owner Zoi Mike sold $86,951 worth of shares (24,024 units at $3.62) (SEC Form 4)

    4 - Motorsport Games Inc. (0001821175) (Issuer)

    2/27/26 6:23:34 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    $ACRX
    $ADMP
    $ALBO
    $AMPS
    Leadership Updates

    Live Leadership Updates

    View All

    Duos Technologies Group, Inc. Signs ~$200M LOI and Appoints Doug Recker as CEO

    3-Year NVIDIA GPU hosting LOI delivers $40M+ annual EBITDA 10MW site secured to accelerate expansion of distributed AI infrastructure in 2026  JACKSONVILLE, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. ("Duos" or the "Company") (NASDAQ:DUOT) has signed a non-binding letter of intent ("LOI") with Hydra Host to deploy a high-density NVIDIA GPU cluster for a leading global technology customer. The project supports an underlying GPU-as-a-Service ("GPUaas") partnership that is expected to generate approximately $176 million in revenue over a 36-month term. The deployment is modeled to support gross margins more than 80% and projected annual EBITDA exceeding $40 million

    2/27/26 8:30:00 AM ET
    $DUOT
    Computer Software: Prepackaged Software
    Technology

    AtaiBeckley Appoints Michael Faerm as Chief Financial Officer

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc (NASDAQ:ATAI) ("AtaiBeckley" or the "Company"), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced the appointment of Michael Faerm as Chief Financial Officer, effective March 9, 2026. Mr. Faerm is a seasoned financial executive with more than 25 years of experience across life sciences companies, equity research, and investment banking. As Chief Financial Officer at AtaiBeckley, he will lead the Company's financial strategy, capital markets activities, and overall financial operations. Anne Johnson, who ha

    2/19/26 7:00:00 AM ET
    $ATAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target, REalloys to Appoint Bob Foresman to its Board of Directors

    Following the Addition of General Jack Keane, REalloys Further Strengthens Board with Addition of Former Vice Chairman of UBS Investment Bank  Blackboxstocks/REalloys Form S-4 has been declared effective by the SEC, and, pending NASDAQ listing approval, the company expects to close the merger DALLAS, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ:BLBX) ("Blackboxstocks" or the "Company") today announced that its merger target, REalloys Inc. ("REalloys"), has entered into a designate director agreement with Bob Foresman. Mr. Foresman will formally join the REalloys Board of Directors upon the closing of the merger between Blackboxstocks and REalloys. Blackboxstocks' regist

    2/18/26 8:00:00 AM ET
    $BLBX
    EDP Services
    Technology

    $ACRX
    $ADMP
    $ALBO
    $AMPS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Natural Gas Services Group Inc.

    SC 13D/A - NATURAL GAS SERVICES GROUP INC (0001084991) (Subject)

    12/13/24 6:13:02 PM ET
    $NGS
    Oilfield Services/Equipment
    Energy

    SEC Form SC 13G filed by Tower Semiconductor Ltd.

    SC 13G - TOWER SEMICONDUCTOR LTD (0000928876) (Subject)

    12/9/24 9:15:24 AM ET
    $TSEM
    Semiconductors
    Technology

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/6/24 4:30:32 PM ET
    $REED

    $ACRX
    $ADMP
    $ALBO
    $AMPS
    Financials

    Live finance-specific insights

    View All

    Ideal Power to Host Fourth Quarter and Full Year 2025 Results Conference Call on March 10, 2026 at 10:00 AM Eastern Time

    AUSTIN, Texas, Feb. 27, 2026 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and provider of its innovative and widely patented B-TRAN® bidirectional semiconductor power switch, today announced management will hold a conference call on Tuesday, March 10, 2026 at 10:00 AM Eastern Time to discuss its results for the fourth quarter and full year ended December 31, 2025. A press release detailing these results will be issued prior to the call.Ideal Power management will host the conference call, followed by a question-and-answer period. Analysts and investors may pose questions for management during the live conference call on March 1

    2/27/26 9:20:00 AM ET
    $IPWR
    Semiconductors
    Technology

    Yalla Group Limited to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026 Eastern Time

    DUBAI, UAE, Feb. 27, 2026 /PRNewswire/ -- Yalla Group Limited ("Yalla" or the "Company") (NYSE:YALA), the largest Middle East and North Africa (MENA)-based online social networking and gaming company, today announced that it will report its unaudited financial results for the fourth quarter and full year 2025 after the U.S. market closes on Monday, March 9, 2026. Yalla Group Limited will hold a conference call on Monday, March 9, 2026, at 8:00 PM Eastern Time, 4:00 AM Dubai Time on Tuesday, March 10, 2026, or 8:00 AM Beijing Time on Tuesday, March 10, 2026, to discuss the financial results.Participants should complete online registration using the link provided below before the scheduled sta

    2/27/26 5:00:00 AM ET
    $YALA
    Computer Software: Programming Data Processing
    Technology

    Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

    Ginkgo provides an update on its fourth quarter financial resultsBOSTON, Feb. 26, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA, ", Ginkgo", )) today announced its results for the fourth quarter and full year ended December 31, 2025. The update, including a webcast slide presentation with additional details on the third quarter, as well as supplemental financial information will be available at investors.ginkgobioworks.com. Fourth Quarter 2025 Financial ResultsFourth quarter 2025 Total revenue of $33 million compared to $44 million in the comparable prior year pe

    2/26/26 4:26:00 PM ET
    $DNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care